au.\*:("HAY, R. J")
Results 1 to 25 of 138
Selection :
Die gegenwärtige Therapie der Dermatomykosen und Onychomykosen = Current therapy of cutaneous mycoses and onychomycosesHAY, R. J.H + G. Zeitschrift für Hautkrankheiten. Supplement. 1993, Vol 68, Num 1, pp 9-12, issn 0342-9687Article
Amorolfine: an innovation in antimycotic therapy. International symposiumHAY, R. J.Clinical and experimental dermatology. Supplement. 1992, Vol 17, Num 1, issn 0966-3487, 71 p.Conference Proceedings
Nocardial infection of the skinHAY, R. J.Journal of hygiene. 1983, Vol 91, Num 3, pp 385-391, issn 0022-1724Article
Tropical fungal infectionsHAY, R. J.Baillière's clinical tropical medicine and communicable diseases. 1989, Vol 4, Num 1, X-290 [300 p.]Serial Issue
The seed stock concept and quality control for cell linesHAY, R. J.Analytical biochemistry. 1988, Vol 171, Num 2, pp 225-237, issn 0003-2697, 13 p.Article
Yeast infectionsHAY, R. J.Dermatologic clinics. 1996, Vol 14, Num 1, issn 0733-8635, ix, 113-124 [13 p.]Article
Risk/benefit ratio of modern antifungal therapy : focus on hepatic reactionsHAY, R. J.Journal of the American Academy of Dermatology. 1993, Vol 29, Num 1, pp S50-S54, issn 0190-9622Conference Paper
Opportunistic fungal infections in the tropicsHAY, R. J.Baillière's clinical tropical medicine and communicable diseases. 1989, Vol 4, Num 1, pp 249-267Article
Tinea imbricata: the factors affecting persistent dermatophytosisHAY, R. J.International journal of dermatology. 1985, Vol 24, Num 9, pp 562-564, issn 0011-9059Article
Preventing cellulitis: where next?HAY, R. J.British journal of dermatology (1951). 2014, Vol 171, Num 6, pp 1304-1306, issn 0007-0963, 3 p.Article
Genetic susceptibility to dermatophytosisHAY, R. J.European journal of epidemiology. 1992, Vol 8, Num 3, pp 346-349, issn 0393-2990Article
Amorlfine, a breakthrough in tropical antimycotic therapy, Montreal, June 26, 1991HAY, R. J.Dermatology. 1992, Vol 184, SUP1Conference Proceedings
Overview of the treatment of disseminated fungal infectionsHAY, R. J.Journal of antimicrobial chemotherapy (Print). 1991, Vol 28, pp 17-25, issn 0305-7453, SUPBArticle
Nouvelle classification clinique des onychomycoses = New clinical classification for onychomycosesBARAN, R; HAY, R.-J.Journal de mycologie médicale. 2014, Vol 24, Num 4, pp 247-260, issn 1156-5233, 14 p.Article
Serological responses to Pityrosporum (Malassezia) in seborrhœic dermatitis demonstrated by ELISA and western blottingMIDGLEY, G; HAY, R. J.Bulletin de la Société française de mycologie médicale. 1988, Vol 17, Num 2, pp 267-276, issn 0037-9336Article
Partial surgical avulsion of the nail in onychomycosisBARAN, R; HAY, R. J.Clinical and experimental dermatology (Print). 1985, Vol 10, Num 5, pp 413-418, issn 0307-6938Article
Antibody responses in tinea imbricata: the role of immunoglobulin EHAY, R. J; SHENNAN, G.Transactions of the Royal Society of Tropical Medicine and Hygiene. 1984, Vol 78, Num 5, pp 653-655, issn 0035-9203Article
Lipid amphotericin B combinations; 'la crème de la crème'?HAY, R. J.The Journal of infection. 1999, Vol 39, Num 1, pp 16-20, issn 0163-4453Conference Paper
Preclinical data and mode of action of amorolfinePOLAK, A.Dermatology. 1992, Vol 184, pp 3-7, SUP1Conference Paper
The future of onychomycosis therapy may involve a combination of approachesHAY, R. J.British journal of dermatology. Supplement. 2001, Vol 145, Num 60, pp 3-8, issn 0366-077XConference Paper
Rapid differentiation between fluconazole-sensitive and -resistant species of Candida directly from positive blood-culture bottles by real-time PCRMETWALLY, L; HOGG, G; MCMULLAN, R et al.Journal of medical microbiology. 2007, Vol 56, Num 7, pp 964-970, issn 0022-2615, 7 p.Article
Trends in candidemia and antifungal susceptibility in a university hospital in Northern Ireland 2001-2006METWALLY, L; WALKER, M. J; COYLE, P. V et al.The Journal of infection. 2007, Vol 55, Num 2, pp 174-178, issn 0163-4453, 5 p.Article
Onychomycosis: the development of a clinical diagnostic aid for toenail disease. Part I. Establishing discriminating historical and clinical featuresFLETCHER, C. L; HAY, R. J; SMEETON, N. C et al.British journal of dermatology (1951). 2004, Vol 150, Num 4, pp 701-705, issn 0007-0963, 5 p.Article
The rationale for combination therapyEVANS, E. G. V.British journal of dermatology. Supplement. 2001, Vol 145, Num 60, pp 9-13, issn 0366-077XConference Paper
Topical amorolfine for 15 months combined with 12 weeks of oral terbinafine, a cost-effective treatment for onychomycosisBARAN, R.British journal of dermatology. Supplement. 2001, Vol 145, Num 60, pp 15-19, issn 0366-077XConference Paper